Lionsgate and AEG Worldwide both took part in a series B round that came alongside the eSports team owner's rebranding to incorporate a gaming platform.

Exosome therapeutics developer Codiak BioSciences, exploiting technology developed by researchers at the universities of Gothenburg and Texas, is eyeing up to $86.3m in an IPO.

General Mills-backed meat substitute developer Beyond Meat priced its shares at the top of an expanded range, but Tyson Foods had already sold its stake.

Alexandria Real Estate Equities-backed exosome therapeutics developer Codiak BioSciences is eyeing up to $86.3m in a forthcoming IPO.

The immuno-oncology therapy developer received funding from investors including Alexandria Real Estate Equities and strategic collaborator Celgene.

Mitsubishi Chemical, Shin-Etsu, Sekisui, Tosoh, Henkel, JSR, PTT GLobal, Adidas, CorrsTek, Severstal and Doosan all contributed to Pangaea Ventures' latest fund.

Riverwood Capital led the banking technology developer's series C round, which came five years after its Intel Capital-backed series B.

Raine Group has led a $70m series C round for VideoAmp, nearly two years after the adtech developer last raised capital, from backers including RTL and Mediaocean.

Goldman Sachs led a round that included Deutsche Telekom Capital Partners and Presidio Ventures, boosting the total raised by SD-WAN technology provider Aryaka to $184m.

Motus, which backs spinouts from a range of universities and research institutes, has secured cash from unnamed investors for its Smart World Innovation Fund.